Antiarrhythmic drugs: Dronedarone associated with increased risk of serious cardiovascular events or deathThe FDA ( Food and Drug Administration ) has completed a safety review of Multaq ( Dronedarone ). This review showed that Multaq increased the risk of serious cardiovascular events, including death, w ...Contraindications for Pradaxa, a new oral anticoagulantThe Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Pradaxa ( Dabigat ...Reduction in atrial fibrillation burden with the fixed-dose combination of Ranolazine and low-dose DronedaroneGilead Sciences has announced results from HARMONY, a randomized, double-blind, placebo-controlled phase 2 study evaluating the effect of Ranolazine and low-dose Dronedarone, each given alone and in c ...Antiarrhythmic drugs to maintain sinus rhythm: recommendationsBefore initiating antiarrhythmic drug therapy, treatment of precipitating or reversible causes of atrial fibrillation is recommended. ( Class I; Level of Evidence: C ) The following antiarrhythmic ...
Arrhythmias Newsletter
Antiarrhythmic drugs: Dronedarone associated with increased risk of serious cardiovascular events or deathThe FDA ( Food and Drug Administration ) has completed a safety review of Multaq ( Dronedarone ). This review showed that Multaq increased the risk of serious cardiovascular events, including death, w ...Contraindications for Pradaxa, a new oral anticoagulantThe Committee for Medicinal Products for Human Use ( CHMP ) has adopted a positive opinion recommending a change to the terms of the marketing authorisation for the medicinal product Pradaxa ( Dabigat ...Reduction in atrial fibrillation burden with the fixed-dose combination of Ranolazine and low-dose DronedaroneGilead Sciences has announced results from HARMONY, a randomized, double-blind, placebo-controlled phase 2 study evaluating the effect of Ranolazine and low-dose Dronedarone, each given alone and in c ...Antiarrhythmic drugs to maintain sinus rhythm: recommendationsBefore initiating antiarrhythmic drug therapy, treatment of precipitating or reversible causes of atrial fibrillation is recommended. ( Class I; Level of Evidence: C ) The following antiarrhythmic ...